期刊文献+

响应面法优化疏螺旋体素发酵培养基 被引量:2

Optimization of fermentation medium for production of borrelidin by response surface methodology
下载PDF
导出
摘要 目的提高链霉菌BOR-0331发酵液中的生物活性成分疏螺旋体素(borrelidin)含量。方法采用单因素实验、Plackett-Burman实验、最陡爬坡试验、中心组合设计实验等方法优化发酵培养基组成及比例。结果当黄豆饼粉2.4%,甘露醇3.2%,可溶性淀粉1.8%,甘油0.7%,氯化钠0.1%时,效价最高。结论经过发酵培养基优化,效价从2.2mg/L提升至35.3mg/L,提高了1504%。 Objective To enhance the productivity of borrelidin with bioactivity by Streptomyces BOR- 0331. Methods The fermentation medium were tested by single-factor experiment Plackett-Burman experiment, the steepest ascent path and Central Composite Design(CCD). Results The productivity had enhanced from 2.2mg/L to 35.3mg/L, increasing by 1504% by using the best combination of medium with soybean meal 2.4%, mannitol 3.2%, soluble starch 1.8%, glycerol 0.7%, sodium chloride 0.1%. Conclusion The fermentation medium was optimized.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2016年第5期344-347,361,共5页 Chinese Journal of Antibiotics
基金 福建省公益类科研院所省重点项目(No.2014R1009-3)
关键词 发酵 培养基优化 疏螺旋体素 响应面法 中心组合设计 Fermentation Medium optimization Borrelidin Response Surface Method(RSM) Central Composite Design(CCD)
  • 相关文献

参考文献18

  • 1Berger J, Jampolsky L M, Goldberg M W. Borrelidin, a newantibiotic with antiborrelia activity and penicillin enhancementproperties[J]. Arch Biochem, 1949,22(3): 476-478.
  • 2Saisivam S, Bhikshapathi D V R N, Krishnaveni J, et alIsolation of borrelidin from Streptomyces californicus-AnIndian soil isolate[J]. Indian JBiotechnol,2008, 7(3): 349-355.
  • 3Liu C X, Zhang J, Wang X J, et al. Antifungai activity ofborrelidin produced by a Streptomyces strain isolated fromsoybeanfJ]. JAgric Food Chem, 2012, 60(5): 1251-1257.
  • 4Gao Y M, Wang X J, Zhang J, et al. Borrelidin, a potent antifungal agent: insight into the antifungal mechanism against Phytophthora sojae[J]. J Agric Food Chem, 2012, 60(39): 9874-9881.
  • 5Lumb M, Macey P E, Spyvee J, et al. Isolation of vivomycinand borrelidin, two antibiotics with anti-viral activity, from aspecies of Streptomyces{C29^9)[J'\. Nature,1965, 206(981):263-265.
  • 6Sugawara A, Tanaka T, Hirose T, et al Borrelidin analogueswith antimalarial activity: design, synthesis and biologicalevaluation against Plasmodium falciparum parasites[J].Bioorg Med Chem Lett, 2013, 23(8): 2302-2305.
  • 7Otoguro K, Ui H,Ishiyama A, et al In vitro and in vivoantimalarial activities of a non-glycosidic 18-memberedmacrolide antibiotic, borrelidin, against drug-resistant strainsof Plasmodia[J]. JAntibiot, 2003,56(8): 727-729.
  • 8Ishiyama A, Iwatsuki M,Namatame M, et al Borrelidin,a potent antimalarial: stage-specific inhibition profile ofsynchronized cultures of Plasmodium falciparum[J]. JAntibiot (Tokyo), 2011, 64(5): 381-384.
  • 9Azcarate I G, Marin-Garcia P, Camacho N, et al Designof antimalarial drugs with immunoprotective activity: theBorrelidin model[J]. Trop Med Int Health, 2011, 16(1): 141.
  • 10Kawamura T, Liu D, Towle M J, et al Anti-angiogenesiseffects of borrelidin are mediated through distinct pathways:threonyl-tRNA synthetase and caspases are independentlyinvolved in suppression of proliferation and induction ofapoptosis in endothelial cells[J]. J Antibiot (Tokyo),2003,56(8): 709-715.

二级参考文献16

  • 1金昌燮,朴顺爱,崔英兰,金星,郭小威.春雷霉素高产菌株US95^#的选育及大罐发酵工艺控制[J].生物学杂志,2004,21(5):34-35. 被引量:5
  • 2Berger J, Jampolsky LM, Goldberg MW. Borrelidin, a new antibiotic with antiborrelia activity and penicillin enhancement properties[J]. Archives of Biochemistry and Biophysics, 1949, 22(3): 476-478.
  • 3Keller-Scheirlein W. Composition of the antibiotic borrelidin[J]. Helvetica Chimica Acta, 1967, 50(3): 731-753.
  • 4Anderson BF, Herlt AJ, Richards RW, et al. Crystal and molecular structures of two isomorphous solvates of the macrolide antibiotic borrelidin: absolute configuration determination by incorporation of a chiral solvent in the crystal lattice[J]. Australian Journal of Chemistry, 1989, 42(5): 717-730.
  • 5Dickinson L, Griffiths A J, Mason CG, et al. Anti-viral activity of two antibiotics isolated from a species of Streptornyces[J]. Nature, 1965, 206(981): 263-265.
  • 6Paetz W, Nass G. Biochemical and immunological characterization of threonyl -tRNA synthetase of two Borrelidin-resistant mutants of Escherichia coli K12[J]. European Journal of Biochemistry, 1973, 35(2): 331-337.
  • 7Wakabayashi T, Kageyama R, Naruse N, et al. Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model[J]. The Journal of Antibiotics, 1997, 50(8): 671-676.
  • 8Tsuchiya E, Yukawa M, Miyakawa T, et al. Borrelidin inhibits a cyclin-dependent kinase (CDK), Cdc28/Cln2, of Saccharomyces cerevisiae[J]. The Journal of Antibiotics, 2001, 54(1): 84-90.
  • 9Saisivam S, Bhikshapathi DVRN, Krishnaveni J, et al. Isolation of borrelidin from Streptomyces californicus-an Indian soil isolate[J]. Indian Journal of Biotechnology, 2008, 7(3): 349-355.
  • 10Lumb M, Macey PE, Spyvee J, et al. Isolation of vivomycin and borrelidin, two antibiotics with anti-viral activity, from a species of Streptomyces[J]. Nature, 1965, 206(4981): 263-265.

共引文献10

同被引文献3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部